PRELUDE THERAPEUTICS INC (PRLD) Free cash flow 2019–2025
PRELUDE THERAPEUTICS INC (PRLD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$56.4MFY2025 · since FY2019: -$26.4M → -$56.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.4M | +45.6% |
| FY2024 | -$103.7M | +6.3% |
| FY2023 | -$110.6M | -27.5% |
| FY2022 | -$86.7M | -1.0% |
| FY2021 | -$85.9M | -83.5% |
| FY2020 | -$46.8M | -77.0% |
| FY2019 | -$26.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice